Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals

Zürcher Kantonalbank and its subsidiaries have filed a Form 8.3 with the Irish Takeover Panel concerning their interests in Avadel Pharmaceuticals plc. As of January 2, 2026, Zürcher Kantonalbank holds 997,540 ordinary shares in Avadel, representing 1.02% of the company's relevant securities. No cash-settled or stock-settled derivatives or other positions were reported. The disclosure adheres to the Irish Takeover Panel Rules, 2022, governing persons holding interests of 1% or more in relevant securities.

No further dealings in other securities classes were disclosed, and no agreements, arrangements, or understandings related to options or derivatives are noted in the filing.